Erika McAlister
Physician Assistant · Pensacola, FLNPI 1891260568
Payments from drug & device makers
Across 174 payments — averaging $23.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$1K
- AbbVie$511
- Boehringer Ingelheim$403
- Arbor Pharmaceuticals, Inc.$271
- AstraZeneca$237
- Pfizer$226
- plus $1K from 21 others
What the payments were for
- Consulting fees$80020%
- Food & beverage$3,21580%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $1,253 |
| AbbVie | 36 | $511 |
| Boehringer Ingelheim | 25 | $403 |
| Arbor Pharmaceuticals, Inc. | 17 | $271 |
| AstraZeneca | 12 | $237 |
| Pfizer | 16 | $226 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $191 |
| Exact Sciences | 5 | $114 |
| GSK | 5 | $111 |
| Lilly USA, LLC | 5 | $102 |
| Biohaven Pharmaceuticals, Inc. | 5 | $97 |
| Johnson & Johnson | 4 | $60 |
| Sanofi-aventis U.S. LLC | 4 | $53 |
| Medtronic | 1 | $53 |
| Amgen | 2 | $42 |
| Dexcom, Inc. | 1 | $40 |
| Shield Therapeutics Inc | 2 | $39 |
| Eisai Inc. | 2 | $38 |
| Novo Nordisk | 2 | $35 |
| Merck | 2 | $33 |
| Phadia US Inc. | 1 | $22 |
| Bausch Health US, LLC | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Lifescan, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Acerus Pharmaceuticals Corporation | 1 | $17 |
| Cequr Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,085
How this compares
$4,039 in reported general payments places this provider in the 85th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 52 | $62,701 |
| JardianceEmpagliflozin | 42 | $58,859 |
| EliquisApixaban | 61 | $55,720 |
| JanuviaSitagliptin Phosphate | 42 | $48,825 |
| XareltoRivaroxaban | 43 | $34,021 |
| FarxigaDapagliflozin Propanediol | 29 | $25,700 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $23,641 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $17,367 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $17,125 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $14,976 |
| LinzessLinaclotide | 17 | $13,003 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $12,600 |
| Bydureon BciseExenatide Microspheres | 11 | $10,819 |
| TradjentaLinagliptin | 15 | $10,068 |
| PremarinEstrogens, Conjugated | 24 | $8,598 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $403 | $68,92857 claims |
| MerckJanuvia, Janumet | $33 | $66,19254 claims |
| PfizerEliquis, Premarin | $226 | $64,31885 claims |
| Novo NordiskOzempic | $35 | $62,70152 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $237 | $38,30049 claims |
| Johnson & JohnsonXarelto | $60 | $34,02143 claims |
| GSKTrelegy Ellipta | $111 | $17,12528 claims |
| AbbVieLinzess, Synthroid | $511 | $14,38141 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Pensacola
- Christopher SmithPensacola$82K
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.